These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18794482)

  • 1. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption.
    Eiling E; Brandt M; Schwarz T; Hauschild A
    Arch Dermatol; 2008 Sep; 144(9):1236-8. PubMed ID: 18794482
    [No Abstract]   [Full Text] [Related]  

  • 2. Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches.
    Nikolaou V; Stratigos A; Antoniou C; Kiagia M; Nikolaou C; Katsambas A; Syrigos K
    Dermatology; 2010; 220(3):243-8. PubMed ID: 20110632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pimecrolimus (Elidel) for a variety of skin diseases].
    Hermanns-Lê T; Hermanns JF; Thirion L; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2006 Apr; 61(4):256-9. PubMed ID: 16789614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pimecrolimus (SDZ ASM 981). Current state of research].
    Dissemond J; Goos M; Wagner SN
    Dtsch Med Wochenschr; 2002 May; 127(22):1199-203. PubMed ID: 12035117
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.
    Scope A; Lieb JA; Dusza SW; Phelan DL; Myskowski PL; Saltz L; Halpern AC
    J Am Acad Dermatol; 2009 Oct; 61(4):614-20. PubMed ID: 19646778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.
    Lacouture ME; Basti S; Patel J; Benson A
    J Support Oncol; 2006 May; 4(5):236-8. PubMed ID: 16724647
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
    Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
    Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papulo-pustular eruption during cetuximab treatment.
    Satta R; Cuccuru MA; Pirodda C; Cottoni F
    G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
    [No Abstract]   [Full Text] [Related]  

  • 10. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A; Baumann K; Grassberger M; Wolff K; Meingassner JG
    Int Arch Allergy Immunol; 2006; 141(3):199-212. PubMed ID: 16926539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy.
    Gutzmer R; Werfel T; Mao R; Kapp A; Elsner J
    Br J Dermatol; 2005 Oct; 153(4):849-51. PubMed ID: 16181478
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovative use of topical calcineurin inhibitors.
    Lin AN
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema].
    Reitamo S; Remitz A
    Duodecim; 2003; 119(9):825-7. PubMed ID: 12815980
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
    Chu CY
    Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal toxic epidermal necrolysis associated with cetuximab in a patient with colon cancer.
    Lin WL; Lin WC; Yang JY; Chang YC; Ho HC; Yang LC; Yang CH; Hung SI; Chung WH
    J Clin Oncol; 2008 Jun; 26(16):2779-80. PubMed ID: 18509187
    [No Abstract]   [Full Text] [Related]  

  • 18. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.
    Krishnan G; D'Silva K; Al-Janadi A
    J Clin Oncol; 2008 May; 26(14):2406-8. PubMed ID: 18467734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease.
    Milcic D; Nikolic M
    Australas J Dermatol; 2012 May; 53(2):e34-5. PubMed ID: 22571582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.